Bruce F. Wesson, Director at ACURA PHARMACEUTICALS, INC (ACUR), bought 335,734 shares at $0.10 ($34K) on 2017-12-14, disclosed to the SEC on 2017-12-15.
Open-market purchase of $34k ACUR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MDAS | SELL | 2013-11-22 | $1.2M | — | Filing → |
| MDAS | BUY | 2011-11-28 | $225K | — | Filing → |
| DSCI | BUY | 2011-11-28 | $75K | — | Filing → |